Static Chart Edwards Lifesciences Corporation

Stocks

Market Closed - NYSE 16:00:03 2026-10-28 EDT			5-day change	1st Jan Change
91.78 ^USD	+1.06%		+3.82%	+7.66%

10-21	Edwards Lifesciences Corporation Receives FDA Approval For PASCAL Precision System For Tricuspid Valve Repair And PASCAL Ace With Capture Clarity System For Degenerative Mitral TEER Procedures	CI
10-21	Edwards Lifesciences Gets Approval for Tricuspid Valve Repair System From US FDA	MT

Duration

Period